OKYO Pharma OKYO
NASDAQ OKYO
$1.46 -0.07 (-4.61%)
As of: Sep 9, 2026 · 3:59 PM EDT

OKYO Pharma (OKYO) Gains from Investment Securities (2024 - 2026)

OKYO Pharma's (OKYO) quarterly Gains from Investment Securities came in at -$700750.0 in Q1 2026, down 460.67% quarter-over-quarter from $194292.0 in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

OKYO Pharma (OKYO) Gains from Investment Securities (2024 - 2026) Analysis & Trends

OKYO Pharma (OKYO) has reported Gains from Investment Securities for 3 consecutive years, with -$700750.0 the latest figure, recorded in Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 OKYO Pharma 1.06 Bn 1.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -700,750.00
Dec 31, 2025 194,292.00
Dec 31, 2024 55,183.00